TGF beta receptor
Transforming Growth Factor Beta Receptor (TGF-β receptor) refers to a set of cell surface receptors that are critical for the regulation of cellular differentiation, proliferation, apoptosis, and other functions in most cells. TGF-β receptors are part of the larger serine/threonine kinase family. They play a pivotal role in cell signaling by the transforming growth factor beta (TGF-β), which is a multifunctional set of peptides that controls various aspects of cellular function.
Structure and Function[edit | edit source]
The TGF-β receptor complex is composed of two main types: Type I (TβRI) and Type II (TβRII) receptors, both of which are necessary for signal transduction. There is also a Type III receptor (TβRIII), which acts as a co-receptor facilitating the binding of TGF-β to TβRII.
Type I Receptor[edit | edit source]
The Type I receptor, also known as activin receptor-like kinase (ALK), upon binding of TGF-β to the Type II receptor, is phosphorylated by TβRII, initiating the signal transduction cascade. There are several ALKs, each mediating different responses to TGF-β signaling.
Type II Receptor[edit | edit source]
The Type II receptor has a constitutively active serine/threonine kinase domain that phosphorylates the Type I receptor upon ligand binding. TβRII is the primary binding site for TGF-β ligands.
Type III Receptor[edit | edit source]
Although not directly involved in signal transduction, the Type III receptor enhances the affinity of TGF-β for its Type II receptor, thus facilitating the signaling process.
Signal Transduction[edit | edit source]
Upon ligand binding, TβRII phosphorylates and activates TβRI, which then propagates the signal through the phosphorylation of SMAD proteins. Specifically, receptor-regulated SMADs (R-SMADs) are phosphorylated, form complexes with co-SMADs, and translocate to the nucleus to regulate gene expression.
Biological Roles[edit | edit source]
TGF-β signaling plays a crucial role in numerous biological processes, including:
- Embryonic development
- Regulation of immune responses
- Wound healing
- Angiogenesis
- Extracellular matrix formation
Dysregulation of TGF-β signaling is implicated in various diseases, including Cancer, Fibrosis, and Cardiovascular diseases.
Clinical Significance[edit | edit source]
Given its role in cell growth and differentiation, the TGF-β receptor pathway is a target for therapeutic intervention in cancer and fibrotic diseases. Inhibitors of TGF-β receptors are being developed to treat these conditions by blocking aberrant signaling pathways.
See Also[edit | edit source]
- Transforming growth factor beta
- Signal transduction
- SMAD proteins
- Serine/threonine-specific protein kinase
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD